IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan - PubMed (original) (raw)

IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan

M A Salih et al. Genes Immun. 2007 Jan.

Abstract

Post-kala-azar dermal leishmanaisis (PKDL) in Sudan is associated with elevated interferon-gamma (IFN-gamma). To study interferon-gamma pathways in PKDL, we genotyped 80 trios from the Masalit ethnic group for polymorphisms at -470 ins/delTT, -270T/C, -56T/C and +95T/C in IFNGR1 and at -179G/A and +874T/A in IFNG. No associations occurred at IFNG. Global association with haplotypes comprising all four markers at IFNGR1 (chi(2)(10df)=21.97, P=0.015) was observed, associated with a significant (chi(2)(1df)=4.54, P=0.033) bias in transmission of the haplotype insTT T T T and less (chi(2)(1df)=5.59, P=0.018) than expected transmission of insTT C C C. When compared with data on malaria associations from Gambia, the results suggest a complex pattern of haplotypic variation at the IFNGR1 promoter locus associated with different infectious disease in African populations that reflect the complex roles of IFN-gamma in parasite killing versus inflammation and pathogenesis.

PubMed Disclaimer

Similar articles

• Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
  Salih MA, Fakiola M, Abdelraheem MH, Younis BM, Musa AM, ElHassan AM, Blackwell JM, Ibrahim ME, Mohamed HS. Salih MA, et al. BMC Infect Dis. 2014 Dec 3;14:662. doi: 10.1186/s12879-014-0662-5. BMC Infect Dis. 2014. PMID: 25466928 Free PMC article.
• Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population.
  Farouk S, Salih MA, Musa AM, Blackwell JM, Miller EN, Khalil EA, Elhassan AM, Ibrahim ME, Mohamed HS. Farouk S, et al. Public Health Genomics. 2010;13(6):362-7. doi: 10.1159/000272457. Epub 2009 Dec 29. Public Health Genomics. 2010. PMID: 20051670 Free PMC article.
• Post-kala-azar dermal leishmaniasis--an overview.
  Ganguly S, Das NK, Barbhuiya JN, Chatterjee M. Ganguly S, et al. Int J Dermatol. 2010 Aug;49(8):921-31. doi: 10.1111/j.1365-4632.2010.04558.x. Int J Dermatol. 2010. PMID: 21128917 Review.
• The immunology of post-kala-azar dermal leishmaniasis (PKDL).
  Zijlstra EE. Zijlstra EE. Parasit Vectors. 2016 Aug 23;9(1):464. doi: 10.1186/s13071-016-1721-0. Parasit Vectors. 2016. PMID: 27553063 Free PMC article. Review.

Cited by

• IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians.
  Cardoso CC, Pereira AC, Brito-de-Souza VN, Dias-Baptista IM, Maniero VC, Venturini J, Vilani-Moreno FR, de Souza FC, Ribeiro-Alves M, Sarno EN, Pacheco AG, Moraes MO. Cardoso CC, et al. Hum Genet. 2010 Nov;128(5):481-90. doi: 10.1007/s00439-010-0872-x. Epub 2010 Aug 17. Hum Genet. 2010. PMID: 20714752
• Genetics and visceral leishmaniasis: of mice and man.
  Blackwell JM, Fakiola M, Ibrahim ME, Jamieson SE, Jeronimo SB, Miller EN, Mishra A, Mohamed HS, Peacock CS, Raju M, Sundar S, Wilson ME. Blackwell JM, et al. Parasite Immunol. 2009 May;31(5):254-66. doi: 10.1111/j.1365-3024.2009.01102.x. Parasite Immunol. 2009. PMID: 19388946 Free PMC article. Review.
• Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.
  Qu HQ, Fisher-Hoch SP, McCormick JB. Qu HQ, et al. Int J Infect Dis. 2011 May;15(5):e305-13. doi: 10.1016/j.ijid.2011.01.004. Epub 2011 Feb 16. Int J Infect Dis. 2011. PMID: 21330176 Free PMC article. Review.
• Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.
  Kumar R, Chauhan SB, Ng SS, Sundar S, Engwerda CR. Kumar R, et al. Front Immunol. 2017 Nov 8;8:1492. doi: 10.3389/fimmu.2017.01492. eCollection 2017. Front Immunol. 2017. PMID: 29167671 Free PMC article. Review.
• Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription.
  Kearney SJ, Delgado C, Eshleman EM, Hill KK, O'Connor BP, Lenz LL. Kearney SJ, et al. J Immunol. 2013 Sep 15;191(6):3384-92. doi: 10.4049/jimmunol.1203510. Epub 2013 Aug 9. J Immunol. 2013. PMID: 23935197 Free PMC article.

References

1. 1. Zijlstra EE, el-Hassan AM. Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg. 2001;95(Suppl 1):S59–76. - PubMed
2. 1. Murray HW, Rubin BY, Rothermel CD. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest. 1983;72:1506–10. - PMC - PubMed
3. 1. Ismail A, El Hassan AM, Kemp K, et al. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile. J Pathol. 1999;189:615–22. - PubMed
4. 1. Gasim S, Elhassan AM, Kharazmi A, et al. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC) Clin Exp Immunol. 2000;119:523–9. - PMC - PubMed
5. 1. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-g-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;26:1941–1949. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • Ovid Technologies, Inc.
  • PubMed Central

• Research Materials

  • NCI CPTC Antibody Characterization Program